USE OF BISPHOPHONATES FOR INHIBITING BONE RESORPTION FOLLOWING IMPLANTATION OF ORTHOPEDIC PROSTHESIS.
摘要
<p>Disclosed is a therapy for treating and for preventing periprosthetic bone loss by the administration of a bisphosphonate bone resorption inhibitor, e.g., alendronate, in patients who have an orthopedic implant device.</p>
